Impact of a criteria-based reimbursement policy on the use of respiratory drugs delivered by nebulizer and health care services utilization in Nova Scotia, Canada.

PubWeight™: 0.90‹?›

🔗 View Article (PMID 16164398)

Published in Pharmacotherapy on September 01, 2005

Authors

George Kephart1, Ingrid S Sketris, Susan K Bowles, Marc E Richard, Charmaine A Cooke

Author Affiliations

1: Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada.

Articles by these authors

Independent pharmacist prescribing in Canada. Can Pharm J (Ott) (2012) 2.20

Collaborative practice in health systems change: the Nova Scotia experience with the Strengthening Primary Care Initiative. Nurs Leadersh (Tor Ont) (2004) 1.50

Association Between Incretin-Based Drugs and the Risk of Acute Pancreatitis. JAMA Intern Med (2016) 1.21

THE VAXED PROJECT: an assessment of immunization education in Canadian health professional programs. BMC Med Educ (2010) 1.05

Monitoring programs for drugs with potential for abuse or misuse in Canada. Can Pharm J (Ott) (2012) 0.97

Economic evaluation of oseltamivir phosphate for postexposure prophylaxis of influenza in long-term care facilities. J Am Geriatr Soc (2005) 0.92

Effect of educational and policy interventions on institutional utilization of wet nebulization respiratory drugs and portable inhalers. Can J Clin Pharmacol (2008) 0.89

Medication persistence rates and factors associated with persistence in patients following stroke: a cohort study. BMC Neurol (2008) 0.87

The geographic accessibility of pharmacies in Nova Scotia. Can Pharm J (Ott) (2013) 0.83

Natural health products in the prevention and treatment of osteoporosis: systematic review of randomized controlled trials. Ann Pharmacother (2006) 0.83

Pharmacists' participation in an inhaled respiratory medication program: reimbursement of professional fees. Ann Pharmacother (2005) 0.82

The impact of statins on health services utilization and mortality in older adults discharged from hospital with ischemic heart disease: a cohort study. BMC Health Serv Res (2009) 0.80

Population prevalence of high dose paracetamol in dispensed paracetamol/opioid prescription combinations: an observational study. BMC Clin Pharmacol (2012) 0.79

Efficacy of natural health products in treating osteoporosis: what is the quality of internet patient advice? Ann Pharmacother (2009) 0.78

Trends in oral antihyperglycemic and insulin use in the Nova Scotia senior population (1993-1999). Can J Clin Pharmacol (2002) 0.77

Effect of an academic detailing intervention on the utilization rate of cyclooxygenase-2 inhibitors in the elderly. Ann Pharmacother (2008) 0.76

Coping strategies used by patients infected with hepatitis C virus who are facing medication costs. Can J Hosp Pharm (2011) 0.76

Effect of utilization policies for fluoroquinolones: a pilot study in nova scotia hospitals. Can J Hosp Pharm (2009) 0.75

Discordance in Utility Measurement in Persons with Neurological Conditions: A Comparison of the SF-6D and the HUI3. Value Health (2017) 0.75

Coping, adapting or self-managing - what is the difference? A concept review based on the neurological literature. J Adv Nurs (2016) 0.75

Analyzing international prescribing patterns and medication use: an approach to assisting in the improvement of health care quality and patient outcomes. Clin Ther (2007) 0.75

Validation of four clinical indicators of preventable drug-related morbidity. Ann Pharmacother (2004) 0.75

Topical corticosteroid prescribing patterns following changes in drug benefit status. Ann Pharmacother (2003) 0.75

Use of physician profiles to influence prescribing of topical corticosteroids. Can J Clin Pharmacol (2005) 0.75